CIENCIASMEDICASNEWS: Probiotics May Help Promote the Immune Response Against Respiratory Sickness

miércoles, 29 de julio de 2020

Probiotics May Help Promote the Immune Response Against Respiratory Sickness

	Respiratory Diseases
	The latest respiratory diseases news from News Medical

Scientists pinpoint protein that plays key role in lung cancer and melanoma progression

Probiotics May Help Promote the Immune Response Against Respiratory Sickness

Since beneficial interventions are not available for most respiratory and flu-like sickness, other solutions are needed to help defend against respiratory tract discomfort. Probiotics may help promote the immune response against respiratory and flu-like sickness.

Learn More Here

			Researchers develop novel and promising approach for treatment of lung cancer A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics.

			Lung cancer study highlights important factors for treating genomically complicated cancers A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.

			A mobile platform for screening lung cancer A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, according to study published today in The Annals of Thoracic Surgery.

			Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.